IXC 0.00% 7.0¢ invex therapeutics ltd

Ann: Invex Granted Type C Meeting with FDA, page-112

  1. 4,932 Posts.
    lightbulb Created with Sketch. 218
    It’s a no brainer just to do a single European trial if the FDA asks for two. Management needs to communicate this better to the market, The FDA decision is a setback but at the moment it is being treated by investors as a success v failure decision.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.000(0.00%)
Mkt cap ! $5.260M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 17731 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 4154 2
View Market Depth
Last trade - 10.28am 31/01/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.